Summary
-
1.
The effect of tetraethylammonium (TEA) and barium on release of noradrenaline (NA) from the cat spleen by nerve stimulation or potassium was investigated.
-
2.
In spleens perfused with normal Krebs solution, the NA output at 5 Hz was barely detectable, and the output at 30 Hz was about 5-fold greater than the output at 5 Hz.
-
3.
TEA (1 mM) or barium (2.5 mM) increased NA output at 5 Hz by 5-fold, but did not enhance it at 30 Hz. A maximal effect of TEA was obtained at about 1–3 mM. Enhancement of NA release by TEA was readily reversible. Output of NA induced by high potassium was not affected by TEA or barium.
-
4.
The effect of TEA on release was related to the external calcium concentration. Insignificant outputs obtained at 5 Hz in 0.1 and 0.5 mM calcium-Krebs solutions were markedly increased by TEA, and were 2- and 5-fold greater than the control output at 5 Hz in normal Krebs solution containing 2.5 mM calcium. TEA enhanced release at all calcium concentrations up to 5 mM, but maximum output was still obtained at 2.5 mM.
-
5.
Increasing the potassium concentrations of normal Krebs solution to 10, 15 and 20 mM depressed NA outputs at 5 Hz by 50, 55 and 75%, respectively. TEA (1 mM) partially antagonized the inhibitory effect of potassium on release, and in zero potassium-Krebs solution it increased output by about 50% over that obtained in normal Krebs solution.
-
6.
The ratio of NA outputs at 30 and 5 Hz during perfusion with Krebs solution containing TEA was about 0.6, and it approached the normal value as the calcium concentration of the perfusion medium was reduced. TEA facilitated release even at 30 Hz in low-calcium solutions.
-
7.
It is suggested that the enhancement of NA release by TEA and barium is due to the greater influx of calcium ions into the sympathetic nerves during the course of an action potential.
Similar content being viewed by others
References
Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminum oxide-trihydroxy indole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther.138, 360–375 (1962)
Armstrong, C. M., Binstock, L.: Anomalous rectification in the squid giant axon injected with tetraethylammonium chloride. J. gen. Physiol.48, 858–872 (1965)
Beaulieu, G., Frank, G. N.: Tetraethylammonium-induced contractions of frog's skeletal muscle. II. Effects on intramuscular nerve endings. Canad. J. Physiol. Pharmacol.45, 833–844 (1967)
Collier, B., Exley, K. A.: Mechanism of the antagonism of tetraethylammonium of neuromuscular block due to d-tubocurarine or calcium deficiency. Nature (Lond.)199, 702–703 (1963)
Gillespie, J. S., Kirpekar, S. M.: The inactivation of infused noradrenaline by the cat spleen. J. Physiol. (Lond.)176, 205–227 (1965)
Gillespie, J. S., Kirpekar, S. M.: The uptake and release of radioactive noradrenaline by the splenic nerves of cats. J. Physiol. (Lond.)187, 51–68 (1966)
Hertting, G., Axelrod, J.: Fate of tritiated noradrenaline at the sympathetic nerve endings. Nature (Lond.)192, 172–173 (1961)
Keynes, R. D., Ritchie, J. M.: The movements of labeled ions in mammalian non-myelinated nerve fibers. J. Physiol. (Lond.)179, 333–367 (1965)
Kirpekar, S. M., Misu, Y.: Release of noradrenaline by splenic nerve stimulation and its dependence on calcium. J. Physiol. (Lond.)188, 219–234 (1967)
Kirpekar, S. M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol.43, 359–369 (1971)
Kirpekar, S. M., Wakade, A. R.: Release of noradrenaline from the cat spleen by potassium. J. Physiol. (Lond.)194, 595–608 (1968)
Kirpekar, S. M., Furchgott, R. F., Wakade, A. R., Prat, J. C.: Inhibition by sympathomimetic amines of the release of norepinephrine evoked by nerve stimulation in the cat spleen. J. Pharmacol. exp. Ther.187, 529–538 (1973)
Kirpekar, S. M., Wakade, A. R., Dixon, W., Prat, J. C.: Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanethidine. J. Pharmacol. exp. Ther.165, 166–175 (1969)
Kirpekar, S. M., Prat, J. C., Puig, M., Wakade, A. R.: Modification of the evoked release of noradrenaline from the perfused cat spleen by various ions and agents. J. Physiol. (Lond.)221, 601–615 (1972)
Koketsu, K.: Action of tetraethylammonium chloride on neuromuscular transmission in frogs. Amer. J. Physiol.193, 213–218 (1958)
Lightman, S. L., Iversen, L. L.: The role of uptake in the extraneuronal metabolism of catecholamines in the isolated rat heart. Brit. J. Pharmacol.37, 638–649 (1969)
Riker, W. F., Jr.: Excitatory and anti-curare properties of acetycholine and related quaternary ammonium compounds at the neuromuscular junction. Pharmacol. Rev.5, 1–86 (1953)
Thoenen, H., Haefely, W., Staehelin, H.: Potentiation by tetraethylammonium of the response of the cat spleen to postganglionic sympathetic nerve stimulation. J. Pharmacol. exp. Ther.157, 532–540 (1967)
Wakade, A. R., Kirpekar, S. M.: Calcium-independent release of H3-norepinephrine from reserpine-pretreated guinea-pig vas deferens and seminal vesicle. J. Pharmacol. exp. Ther.190, 451–458 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirpekar, S.M., Wakade, A.R. & Prat, J.C. Effect of tetraethylammonium and barium on the release of noradrenaline from the perfused cat spleen by nerve stimulation and potassium. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 23–29 (1976). https://doi.org/10.1007/BF00692781
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00692781